Skip to content
Search

Latest Stories

The before and after pictures that lay bare the myth of 10 stone-plus weight loss diets: These 3 champion slimmers piled on the pounds after winning their prizes

  • Seven years ago, Harriet Jenkins became Slimming World's Woman of the Year
  • But just weeks after the competition ended, her weight started creeping back 
  • She's one of many 'Super Slimmers' to feature in a new Channel 4 documentary
  • The show explores why such dramatic weight loss can be so difficult to maintain

Harriet Jenkins is watching an old video of herself from seven years ago. She's filmed standing on a stage, wearing a little black dress and pearls, with her blonde hair swept glamorously back.


https://variety.com/2017/digital/news/watch-super-bowl-ads-commercials-online-1201979015/

Her name is called and she clasps her hand to her mouth in disbelief as the crowd bursts into applause.

It might have been the Oscars, given her reaction — and she looks every inch the star. At that moment she was. Harriet, a teacher from Southampton, had become a celebrity of the dieting world: Slimming World's Woman of the Year.

Harriet, who's 5 ft 8 in, once weighed 26 st, but she lost 15 st in 15 months, going from size 30 to a size ten.

Harriet Jenkins (pictured), a teacher from Southampton, was once a celebrity of the dieting world: Slimming World's Woman of the Year

Harriet Jenkins (pictured), a teacher from Southampton, was once a celebrity of the dieting world: Slimming World's Woman of the Year. Harriet, who's 5 ft 8 in, once weighed 26 st, but she lost 15 st in 15 months, going from size 30 to a size ten

Harriet Jenkins, pictured at the Slimmer of the Year competition in 2010

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less